J. Hall

Preoperative bone scans. Use in women with early breast cancer.

L. Malmud, N. D. Charkes, W. Maier, 1975, JAMA.

Predictive markers for normal tissue reactions: fantasy or reality?

M. Fernet, J. Hall, 2008, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.

Factors influencing p53 expression in ovarian cancer as a biomarker of clinical outcome in multicentre studies

Jacqueline A. Hall, Robert Brown, H. Hollema, 2006, British Journal of Cancer.

Reply: The classification of p53 immunohistochemical staining results and patient outcome in ovarian cancer

H. Hollema, A. Crijns, S. de Jong, 2007, British Journal of Cancer.

Combination of mTOR inhibition and paclitaxel as a personalised strategy in the context of MYC-amplified high-grade serous ovarian cancer

M. Jimenez-Linan, J. Brenton, A. Piskorz, 2019, Annals of Oncology.